What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis? - Wikidata - awgldk - TriplyDB

What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?

What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?

http://www.wikidata.org/entity/Q33765738

about

The development and assessment of biological treatments for children.The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis.Infection-Related Death among Persons with Refractory Juvenile Idiopathic Arthritis.Novel treatment options for juvenile idiopathic arthritis.A safety evaluation of canakinumab for the treatment of systemic onset juvenile idiopathic arthritis.Risks of serious infections in children treated with biologic response-modifying drugs: Bacterial infection risk in children with juvenile idiopathic arthritis.Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).Serious Adverse Events Associated with Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in A Real-Life Setting.

P2860

Q35135936-20E5D7EB-E3F6-41F6-8DEB-1E20ABEEF661 Q37274470-8904F522-B162-4074-BC2D-418DBBCBF729 Q37288106-11DD543B-0D72-42AF-818E-0731A50ACEF7 Q38570721-DC198534-D217-4875-8E00-8E34E7E5BADB Q38633441-BD1C2306-BC03-4231-95BD-AD123EF31B3C Q40151899-632AB935-B6E1-4392-A4CB-D04FA4799483 Q40995768-405C0A2F-6F39-4C80-A5F7-ECCFC11336BE Q47198925-1ABD6855-1873-4387-81F2-4E435F3B5B15

P2860

What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?

http://www.wikidata.org/entity/Q33765738

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

What are the immunological con ...... juvenile idiopathic arthritis?

@ast

What are the immunological con ...... juvenile idiopathic arthritis?

@en

type

label

What are the immunological con ...... juvenile idiopathic arthritis?

@ast

What are the immunological con ...... juvenile idiopathic arthritis?

@en

prefLabel

What are the immunological con ...... juvenile idiopathic arthritis?

@ast

What are the immunological con ...... juvenile idiopathic arthritis?

@en

P1433

Q33765738-E16B7FB5-6A3D-406A-AC43-0F2F65D30A62

P1476

Q33765738-CA8C6A4F-1648-4402-87CA-EA2372D7796F

P2093

Q33765738-354D807B-43D4-4945-9433-B48023420A51

Q33765738-66EE852A-35E8-4449-8BA8-A470C4BCB811

Q33765738-EF7BF2EE-CD08-4396-8A06-49D5B4C4A3EF

P2860

Q33765738-055086B8-52B7-4487-8F3F-DB780CAE8326

Q33765738-1490E297-E418-49EA-98B1-1A9A521E38F3

Q33765738-1B4FE41C-6D06-46E5-AC52-0D5DCCAF0B22

Q33765738-1F0A2692-D788-4A31-8355-B803F727C22A

Q33765738-26EB84C0-A5C9-4491-8DED-277DD6D4077C

Q33765738-278FFBF6-9C1E-4C5F-99DB-B6FA3A0B9B60

Q33765738-2C9902E4-8DE6-4B56-8D01-A14A629256BF

Q33765738-359DD1B3-C239-44FF-8051-4C59834E239C

Q33765738-3683C181-CD45-409C-B913-E5038B06E937

Q33765738-398FBB06-B375-400E-99D4-90017C1F5590

P2888

Q33765738-29FDB36A-F48B-454A-B412-DEF7A9E00B53

P304

Q33765738-8ED43CF2-1E23-4526-9DCE-AB094937BB5E

P31

Q33765738-76B4F39C-55C2-4CC5-B3A7-5BBA86EFC003

Q33765738-79148503-84EA-4673-A779-EC35618B3426

P356

Q33765738-FF1C0A19-945B-45E3-B139-5481B5173CB5

P433

Q33765738-E052C6A5-6407-4940-A499-387C77740C4D

P478

Q33765738-B3F7F180-0C97-499E-B77B-23F15B86BC67

P577

Q33765738-052D6B17-8BEA-4049-8E4C-0DCC51C89154

P5875

Q33765738-4A94DD0E-3339-4EC4-B645-869198A6257D

P6179

Q33765738-CD0D0656-1E15-4CE8-8F1B-52EF84B4CD0C

P698

Q33765738-283DCD72-DD9D-4695-A33F-2997CA77F6B1

P921

Q33765738-CB344709-1F31-4CAE-86F1-5B504359131D

P932

Q33765738-CA1B9B03-3643-401C-BBF4-C7DD6E26D407

P356

P1433

Arthritis Research and Therapy

P1476

What are the immunological con ...... juvenile idiopathic arthritis?

@en

P2093

Joost F Swart

http://www.w3.org/2001/XMLSchema#string

Nico M Wulffraat

http://www.w3.org/2001/XMLSchema#string

Sytze de Roock

http://www.w3.org/2001/XMLSchema#string

P2860

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis.

Characterization of noncovalent complexes of recombinant human monoclonal antibody and antigen using cation exchange, size exclusion chromatography, and BIAcore.

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis.

Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.

Summary of worldwide pediatric malignancies reported after exposure to etanercept.

P2888

P304

213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR4213

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237016155

http://www.w3.org/2001/XMLSchema#string

P6179

1010605769

http://www.w3.org/2001/XMLSchema#string

P698

23731900

http://www.w3.org/2001/XMLSchema#string

P921

juvenile rheumatoid arthritis

P932

4060240

http://www.w3.org/2001/XMLSchema#string